Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.29 USD | +1.12% | -4.22% | -0.11% |
May. 24 | UBS Adjusts Medtronic Price Target to $76 From $75, Maintains Sell Rating | MT |
May. 24 | Bernstein Adjusts Price Target on Medtronic to $96 From $97 | MT |
Business Summary
- general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.;
- cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.;
- vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.;
- spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity;
- neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%);
- diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps;
- neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc.
Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Number of employees: 95,000
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cardiovascular
37.1
%
| 11,423 | 36.1 % | 11,573 | 37.1 % | +1.31% |
Neuroscience
28.7
%
| 8,784 | 27.7 % | 8,959 | 28.7 % | +1.99% |
Medical Surgical
27.0
%
| 9,141 | 28.8 % | 8,433 | 27.0 % | -7.75% |
Diabetes
7.2
%
| 2,338 | 7.4 % | 2,262 | 7.2 % | -3.25% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
52.4
%
| 16,134 | 50.9 % | 16,373 | 52.4 % | +1.48% |
Non-United States Developed Markets
29.8
%
| 10,025 | 31.6 % | 9,310 | 29.8 % | -7.13% |
Emerging Markets
17.4
%
| 5,426 | 17.1 % | 5,446 | 17.4 % | +0.37% |
Ireland
0.3
%
| 101 | 0.3 % | 98 | 0.3 % | -2.97% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 15-01-25 |
Karen Parkhill
DFI | Director of Finance/CFO | 58 | 16-05-31 |
Gregory Smith
COO | Chief Operating Officer | 63 | 21-03-31 |
Laura Mauri
CTO | Chief Tech/Sci/R&D Officer | - | 18-08-31 |
Chief Tech/Sci/R&D Officer | 63 | 23-05-31 | |
Investor Relations Contact | - | 99-05-31 | |
Sean Salmon
PRN | Corporate Officer/Principal | - | 03-12-31 |
Noel Colon
PRN | Corporate Officer/Principal | - | 08-02-29 |
Yushao Gu
PRN | Corporate Officer/Principal | 55 | 14-12-31 |
Raman Venkatesh
PRN | Corporate Officer/Principal | - | Feb. 20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Donnelly
BRD | Director/Board Member | 62 | 12-12-31 |
Kendall Powell
BRD | Director/Board Member | 70 | 06-12-31 |
Randall Hogan
BRD | Director/Board Member | 68 | 14-12-31 |
Denise O'Leary
BRD | Director/Board Member | 66 | 99-12-31 |
Craig Arnold
BRD | Director/Board Member | 64 | 15-01-25 |
Kevin Lofton
BRD | Director/Board Member | 69 | 20-09-14 |
Lidia Fonseca
BRD | Director/Board Member | 55 | 22-06-26 |
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 15-01-25 |
Elizabeth Nabel
BRD | Director/Board Member | 72 | 13-12-31 |
Gregory Lewis
BRD | Director/Board Member | 53 | 23-06-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,311,337,531 | 1,298,224,156 ( 99.00 %) | 0 | 99.00 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
5,868,916 | 16.40% | 26,057,987 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Medtronic Engineering & Innovation Center Pvt Ltd.
| |
Medtronic AF Luxembourg SARL
Medtronic AF Luxembourg SARL Financial ConglomeratesFinance Part of Medtronic Plc, Medtronic AF Luxembourg SARL is an investment holding Luxembourger company. The company is located in Luxembourg. |
Financial Conglomerates
|
Medical Education YK
| |
Medtronic Holdings SARL
| |
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. |
Medical Specialties
|
India Medtronic Pvt Ltd.
India Medtronic Pvt Ltd. Medical SpecialtiesHealth Technology Part of Medtronic Plc, India Medtronic Pvt Ltd. is a healthcare technology company founded in 1993. The company is based in Mumbai, India and engineers solutions through partnerships to improve healthcare. The Indian company's latest product, the MiniMed™ 780G system, has received FDA approval and allows for real-time insulin adjustments and corrections. |
Medical Specialties
|
Medtronic Holding Hungary Kft.
| |
Medtronic Finance Holdings ULC
Medtronic Finance Holdings ULC Financial ConglomeratesFinance Part of Medtronic Plc, Medtronic Finance Holdings ULC is an investment holding Caymanian company. The company is located in the Cayman Islands. |
Financial Conglomerates
|
MDT Turkey Finansal Danismanlik Ltd. Sti.
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.11% | 108B | |
-5.56% | 181B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.11B | |
+4.91% | 41.3B | |
+21.98% | 31.6B | |
+14.45% | 25.03B | |
-5.81% | 24.16B | |
-4.35% | 23.95B |
- Stock Market
- Equities
- MDT Stock
- Company Medtronic plc